Proposing Bromo-Epi-Androsterone for Neurologic Long-COVID

• DOI: 10.20944/preprints202407.0115.v1
• Publication Date: 2024-07-02T08:18:49Z
• Authors: Coad Thomas Dow
• Keywords: 2019-20 coronavirus outbreak; Proxy (statistics)

The neurologic effects of long-COVID are a therapeutic challenge. This article discusses the immunologic manifestations and proposes non-androgenic, synthetic analog dehydroepiandrosterone (DHEA), bromo-epi-androsterone (BEA), as candidate for clinical trials this exigent collection conditions. Moreover, because there is an association between Alzheimer’s disease, evaluation BEA in may serve proxy its effect on neuroinflammatory biomarkers disease that shared with long-COVID.